Business Description
Treatment com AI Inc
NAICS : 923120
SIC : 8699
ISIN : CA8949421017
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.45 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.6 | |||||
3-Year EPS without NRI Growth Rate | 30.2 | |||||
3-Year FCF Growth Rate | 45.1 | |||||
3-Year Book Growth Rate | 21.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.17 | |||||
9-Day RSI | 38.05 | |||||
14-Day RSI | 37.59 | |||||
6-1 Month Momentum % | 25 | |||||
12-1 Month Momentum % | 25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.56 | |||||
Cash Ratio | 1.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -79.7 | |||||
Shareholder Yield % | -8.33 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -604.55 | |||||
ROIC % | -851.24 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 170 | |||||
PB Ratio | 63.75 | |||||
Price-to-Tangible-Book | 51 | |||||
EV-to-EBIT | -4.23 | |||||
EV-to-EBITDA | -4.23 | |||||
EV-to-FCF | -9.83 | |||||
Price-to-Net-Current-Asset-Value | 51 | |||||
Price-to-Net-Cash | 51 | |||||
Earnings Yield (Greenblatt) % | -23.64 | |||||
FCF Yield % | -10.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Treatment com AI Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.36 | ||
Beta | -0.43 | ||
Volatility % | 74.29 | ||
14-Day RSI | 37.59 | ||
14-Day ATR (C$) | 0.04548 | ||
20-Day SMA (C$) | 0.5655 | ||
12-1 Month Momentum % | 25 | ||
52-Week Range (C$) | 0.355 - 1.11 | ||
Shares Outstanding (Mil) | 55.16 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Treatment com AI Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Treatment com AI Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Treatment com AI Inc Frequently Asked Questions
What is Treatment com AI Inc(XCNQ:TRUE)'s stock price today?
When is next earnings date of Treatment com AI Inc(XCNQ:TRUE)?
Does Treatment com AI Inc(XCNQ:TRUE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |